Englander Institute for Precision Medicine

ATP and cancer immunosurveillance.

TitleATP and cancer immunosurveillance.
Publication TypeJournal Article
Year of Publication2021
AuthorsKepp O, Bezu L, Yamazaki T, Di Virgilio F, Smyth MJ, Kroemer G, Galluzzi L
JournalEMBO J
Volume40
Issue13
Paginatione108130
Date Published2021 Jul 01
ISSN1460-2075
KeywordsAdenosine Triphosphate, Animals, Humans, Neoplasms, Signal Transduction, Tumor Microenvironment
Abstract

While intracellular adenosine triphosphate (ATP) occupies a key position in the bioenergetic metabolism of all the cellular compartments that form the tumor microenvironment (TME), extracellular ATP operates as a potent signal transducer. The net effects of purinergic signaling on the biology of the TME depend not only on the specific receptors and cell types involved, but also on the activation status of cis- and trans-regulatory circuitries. As an additional layer of complexity, extracellular ATP is rapidly catabolized by ectonucleotidases, culminating in the accumulation of metabolites that mediate distinct biological effects. Here, we discuss the molecular and cellular mechanisms through which ATP and its degradation products influence cancer immunosurveillance, with a focus on therapeutically targetable circuitries.

DOI10.15252/embj.2021108130
Alternate JournalEMBO J
PubMed ID34121201
PubMed Central IDPMC8246257

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021